PMC:7102662 / 10097-10949 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T26","span":{"begin":511,"end":516},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma7088"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T13","span":{"begin":511,"end":516},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T105","span":{"begin":470,"end":478},"obj":"Disease"},{"id":"T106","span":{"begin":500,"end":524},"obj":"Disease"},{"id":"T107","span":{"begin":511,"end":524},"obj":"Disease"}],"attributes":[{"id":"A105","pred":"mondo_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0005009"},{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0005252"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T59","span":{"begin":296,"end":301},"obj":"http://purl.obolibrary.org/obo/CLO_0001236"},{"id":"T60","span":{"begin":389,"end":390},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T61","span":{"begin":511,"end":516},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T62","span":{"begin":511,"end":516},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T63","span":{"begin":511,"end":516},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T64","span":{"begin":511,"end":516},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T31","span":{"begin":500,"end":524},"obj":"Phenotype"}],"attributes":[{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0001635"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}

{"project":"LitCovid-sentences","denotations":[{"id":"T86","span":{"begin":0,"end":171},"obj":"Sentence"},{"id":"T87","span":{"begin":172,"end":299},"obj":"Sentence"},{"id":"T88","span":{"begin":300,"end":422},"obj":"Sentence"},{"id":"T89","span":{"begin":423,"end":534},"obj":"Sentence"},{"id":"T90","span":{"begin":535,"end":612},"obj":"Sentence"},{"id":"T91","span":{"begin":613,"end":852},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T205","span":{"begin":511,"end":516},"obj":"UBERON:0000948"},{"id":"T206","span":{"begin":541,"end":548},"obj":"UBERON:0000948"},{"id":"T207","span":{"begin":607,"end":611},"obj":"GO:0016265"},{"id":"T208","span":{"begin":687,"end":693},"obj":"GO:0016265"},{"id":"T144","span":{"begin":132,"end":142},"obj":"UBERON:0001004"},{"id":"T145","span":{"begin":164,"end":174},"obj":"UBERON:0002349"},{"id":"T146","span":{"begin":229,"end":239},"obj":"UBERON:0002349"},{"id":"T147","span":{"begin":270,"end":278},"obj":"UBERON:0005985"},{"id":"T148","span":{"begin":279,"end":289},"obj":"GO:0007596"},{"id":"T149","span":{"begin":364,"end":372},"obj":"UBERON:0005985"},{"id":"T150","span":{"begin":373,"end":378},"obj":"UBERON:0000178"},{"id":"T151","span":{"begin":433,"end":443},"obj":"UBERON:0002349"},{"id":"T152","span":{"begin":456,"end":469},"obj":"GO:0007596"},{"id":"T153","span":{"begin":595,"end":600},"obj":"CHEBI:36044;CHEBI:36044"},{"id":"T154","span":{"begin":602,"end":617},"obj":"CHEBI:50858;CHEBI:50858"},{"id":"T155","span":{"begin":655,"end":663},"obj":"SP_7"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}

{"project":"LitCovid-PubTator","denotations":[{"id":"323","span":{"begin":328,"end":336},"obj":"Species"},{"id":"324","span":{"begin":579,"end":587},"obj":"Species"},{"id":"325","span":{"begin":598,"end":606},"obj":"Species"},{"id":"326","span":{"begin":774,"end":782},"obj":"Species"},{"id":"327","span":{"begin":470,"end":478},"obj":"Disease"},{"id":"328","span":{"begin":500,"end":524},"obj":"Disease"},{"id":"329","span":{"begin":541,"end":560},"obj":"Disease"},{"id":"330","span":{"begin":607,"end":611},"obj":"Disease"},{"id":"331","span":{"begin":687,"end":693},"obj":"Disease"}],"attributes":[{"id":"A323","pred":"tao:has_database_id","subj":"323","obj":"Tax:9606"},{"id":"A324","pred":"tao:has_database_id","subj":"324","obj":"Tax:9606"},{"id":"A325","pred":"tao:has_database_id","subj":"325","obj":"Tax:9606"},{"id":"A326","pred":"tao:has_database_id","subj":"326","obj":"Tax:9606"},{"id":"A327","pred":"tao:has_database_id","subj":"327","obj":"MESH:D003920"},{"id":"A328","pred":"tao:has_database_id","subj":"328","obj":"MESH:D006333"},{"id":"A329","pred":"tao:has_database_id","subj":"329","obj":"MESH:D006331"},{"id":"A330","pred":"tao:has_database_id","subj":"330","obj":"MESH:D003643"},{"id":"A331","pred":"tao:has_database_id","subj":"331","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome."}